PF-07976016

· Pfizer

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for PF-07976016, covering 2024-09-23 to 2026-02-06. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Learn About the Study Medicine Called PF-07976016 in Adults With Obesity [Phase 2]